Original Data

Get Permission
Rev Diabet Stud, 2006, 3(4):189-199 DOI 10.1900/RDS.2006.3.189

Can Stevioside in Combination with a Soy-Based Dietary Supplement Be a New Useful Treatment of Type 2 Diabetes? An In Vivo Study in the Diabetic Goto-Kakizaki Rat

Per B. Jeppesen, Stig E. Dyrskog, Andreas Agger, Soren Gregersen, Michele Colombo, Jianzhong Xiao, Kjeld Hermansen

Department of Endocrinology and Metabolism C, Aarhus University Hospital, Aarhus Sygehus THG, DK-Aarhus C, Denmark.
Address correspondence to: Per Bendix Jeppesen, e-mail: per.bendix.jeppesen@ki.au.dk

Keywords: type 2 diabetes mellitus, metabolic syndrome, stevioside, soy-protein isolate, GK-rats

Abstract

The diterpene glycoside stevioside (SVS) and soy bean protein isolate have both been shown to have beneficial effects in diabetes treatment. As they each show different benefits we investigated whether the combination of both substances shows an improvement in the treatment of diabetes in Goto-Kakizaki (GK) rats. Over the course of 4 wk, the rats were fed with the following four test diets (n = 12 per group): 1. Standard carbohydrate-rich laboratory diet (chow), 2. chow + SVS (0.03 g/kg BW/day), 3. 80% SPI + 20% chow and 4. 80% SPI + 20 % chow + SVS (0.03 g/kg BW/day). At the end of the course conscious rats underwent an intra-arterial glucose tolerance test (IAGTT) (2.0 g glucose/kg BW). Compared to normal chow diet, stevioside in combination with SPI shows the following beneficial effects in GK rats with mild type 2 diabetes: 1. a 56% reduction in plasma glucose (p < 0.001), 2. a 118% increase in first-phase insulin (p < 0.005), 3. a 20% reduction in glucagons (p < 0.05), 4. a 28% reduction in total cholesterol (p < 0.001), 5. a 13% reduction in FFA (p < 0.01), 6. a 49% reduction in TG (p < 0.001) and 7. a 11% reduction in the systolic blood pressure (p < 0.001). In conclusion, the combination of stevioside and SPI has synergistic positive effects on the characteristic features of the metabolic syndrome, i.e. hyperglycemia, hypertension and dyslipidemia.

Fulltext: HTML , PDF (313KB)


This article has been cited by other articles:

Combating combination of hypertension and diabetes in different rat models

Rosenthal T, Younis F, Alter A

Pharmaceuticals 2010. 3(4):916-939

Evaluation of steviol injection on chicken embryos: effects on post-hatch development, proportional organ weights, plasma thyroid hormones and metabolites

Daneshyar M, Geuns JM, Buyse JG, Kermanshahi H, Willemsen H, Ansari Z, Decuypere E, Everaert N

J Poult Sci 2010. 47(1):71-76

Long-term exposure to genistein improves insulin secretory function of pancreatic beta-cells

Fu Z, Liu D

Eur J Pharmacol 2009. 616(1-3):321-327

Stevioside and related compounds: Therapeutic benefits beyond sweetness

Chatsudthipong V, Muanprasat C

Pharmacol Ther 2009. 121(1):41-54

Increased insulin sensitivity and changes in the expression profile of key insulin regulatory genes and beta cell transcription factors in diabetic KKAy-mice after feeding with a soy bean protein rich diet high in isoflavone content

Nordentoft I, Jeppesen PB, Hong J, Abudula R, Hermansen K

J Agric Food Chem 2008. 56(12):4377-4385

Specific immunomodulatory and secretory activities of stevioside and steviol in intestinal cells

Boonkaewwan C, Ao M, Toskulkao C, Rao MC

J Agric Food Chem 2008. 56(10):3777-3784

A natural plant-derived dihydroisosteviol prevents cholera toxin-induced intestinal fluid secretion

Pariwat P, Homvisasevongsa S, Muanprasat C, Chatsudthipong V

J Pharmacol Exp Ther 2008. 324(2):798-805

Soy and cardio-metabolic abnormalities: an update

Azadbakht L, Esmaillzadeh A

J Res Med Sci 2008. 13(2):88-96